As of 2026-08-24, Avalyn Pharma Inc. Common Stock (AVLN) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.1%, relative volume 0.91×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
AVLN is held by 4 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $456K notional. Top 3 carry $517K.
Held by 4 ETFs · $525K across latest filings · largest weight 0.00% (VTWG).
Top 4 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.00% | $456K | new |
| VTWG | 0.00% | $45K | new |
| VTWV | 0.00% | $17K | new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $8K | new |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Not enough history to compute monthly seasonality for AVLN.